These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 9485022)
21. Differential modulation of cyclin-dependent kinase inhibitor p27Kip1 by negative signaling via the antigen receptor of B cells and positive signaling via CD40. Han H; Nomura T; Honjo T; Tsubata T Eur J Immunol; 1996 Oct; 26(10):2425-32. PubMed ID: 8898956 [TBL] [Abstract][Full Text] [Related]
22. Disruption of the actin cytoskeleton leads to inhibition of mitogen-induced cyclin E expression, Cdk2 phosphorylation, and nuclear accumulation of the retinoblastoma protein-related p107 protein. Reshetnikova G; Barkan R; Popov B; Nikolsky N; Chang LS Exp Cell Res; 2000 Aug; 259(1):35-53. PubMed ID: 10942577 [TBL] [Abstract][Full Text] [Related]
23. Momilactone B induces apoptosis and G1 arrest of the cell cycle in human monocytic leukemia U937 cells through downregulation of pRB phosphorylation and induction of the cyclin-dependent kinase inhibitor p21Waf1/Cip1. Park C; Jeong NY; Kim GY; Han MH; Chung IM; Kim WJ; Yoo YH; Choi YH Oncol Rep; 2014 Apr; 31(4):1653-60. PubMed ID: 24503697 [TBL] [Abstract][Full Text] [Related]
24. A vitamin D3 analog induces a G1-phase arrest in CaCo-2 cells by inhibiting cdk2 and cdk6: roles of cyclin E, p21Waf1, and p27Kip1. Scaglione-Sewell BA; Bissonnette M; Skarosi S; Abraham C; Brasitus TA Endocrinology; 2000 Nov; 141(11):3931-9. PubMed ID: 11089522 [TBL] [Abstract][Full Text] [Related]
25. Modulation of the p27kip1 cyclin-dependent kinase inhibitor expression during IL-4-mediated human B cell activation. Blanchard DA; Affredou MT; Vazquez A J Immunol; 1997 Apr; 158(7):3054-61. PubMed ID: 9120257 [TBL] [Abstract][Full Text] [Related]
26. The fate of pancreatic tumor cell lines following p16 overexpression depends on the modulation of CDK2 activity. Calbó J; Serna C; Garriga J; Graña X; Mazo A Cell Death Differ; 2004 Oct; 11(10):1055-65. PubMed ID: 15309028 [TBL] [Abstract][Full Text] [Related]
27. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity. Coppock DL; Buffolino P; Kopman C; Nathanson L Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260 [TBL] [Abstract][Full Text] [Related]
28. Overexpression of c-fos inhibits down-regulation of a cyclin-dependent kinase-2 inhibitor p27Kip1 in splenic B cells activated by surface Ig cross-linking. Kobayashi K; Phuchareon J; Inada K; Tomita Y; Koizumi T; Hatano M; Miyatake S; Tokuhisa T J Immunol; 1997 Mar; 158(5):2050-6. PubMed ID: 9036948 [TBL] [Abstract][Full Text] [Related]
29. Cyclin E-cdk2 activation is associated with cell cycle arrest and inhibition of DNA replication induced by the thymidylate synthase inhibitor Tomudex. Yin MB; Guo B; Panadero A; Frank C; Wrzosek C; Slocum HK; Rustum YM Exp Cell Res; 1999 Feb; 247(1):189-99. PubMed ID: 10047461 [TBL] [Abstract][Full Text] [Related]
30. CaMK-II inhibition reduces cyclin D1 levels and enhances the association of p27kip1 with Cdk2 to cause G1 arrest in NIH 3T3 cells. Morris TA; DeLorenzo RJ; Tombes RM Exp Cell Res; 1998 May; 240(2):218-27. PubMed ID: 9596994 [TBL] [Abstract][Full Text] [Related]
31. Early G1 growth arrest of hybridoma B cells by DMSO involves cyclin D2 inhibition and p21[CIP1] induction. Ponzio G; Loubat A; Rochet N; Turchi L; Rezzonico R; Farahi Far D; Dulic V; Rossi B Oncogene; 1998 Sep; 17(9):1159-66. PubMed ID: 9764826 [TBL] [Abstract][Full Text] [Related]
32. Increased p27Kip1 cyclin-dependent kinase inhibitor gene expression following anti-IgM treatment promotes apoptosis of WEHI 231 B cells. Wu M; Bellas RE; Shen J; Yang W; Sonenshein GE J Immunol; 1999 Dec; 163(12):6530-5. PubMed ID: 10586045 [TBL] [Abstract][Full Text] [Related]
33. Changes in E2F complexes containing retinoblastoma protein family members and increased cyclin-dependent kinase inhibitor activities during terminal differentiation of cardiomyocytes. Flink IL; Oana S; Maitra N; Bahl JJ; Morkin E J Mol Cell Cardiol; 1998 Mar; 30(3):563-78. PubMed ID: 9515032 [TBL] [Abstract][Full Text] [Related]
34. Cancer dormancy and cell signaling: induction of p21(waf1) initiated by membrane IgM engagement increases survival of B lymphoma cells. Marches R; Hsueh R; Uhr JW Proc Natl Acad Sci U S A; 1999 Jul; 96(15):8711-5. PubMed ID: 10411940 [TBL] [Abstract][Full Text] [Related]
35. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells. Said TK; Medina D Mol Carcinog; 1998 Jun; 22(2):128-43. PubMed ID: 9655257 [TBL] [Abstract][Full Text] [Related]
36. Lactoferrin inhibits G1 cyclin-dependent kinases during growth arrest of human breast carcinoma cells. Damiens E; El Yazidi I; Mazurier J; Duthille I; Spik G; Boilly-Marer Y J Cell Biochem; 1999 Sep; 74(3):486-98. PubMed ID: 10412049 [TBL] [Abstract][Full Text] [Related]
37. Transforming growth factor beta 1 increases the stability of p21/WAF1/CIP1 protein and inhibits CDK2 kinase activity in human colon carcinoma FET cells. Gong J; Ammanamanchi S; Ko TC; Brattain MG Cancer Res; 2003 Jun; 63(12):3340-6. PubMed ID: 12810668 [TBL] [Abstract][Full Text] [Related]
38. Biphasic regulation of breast cancer cell growth by progesterone: role of the cyclin-dependent kinase inhibitors, p21 and p27(Kip1). Groshong SD; Owen GI; Grimison B; Schauer IE; Todd MC; Langan TA; Sclafani RA; Lange CA; Horwitz KB Mol Endocrinol; 1997 Oct; 11(11):1593-607. PubMed ID: 9328342 [TBL] [Abstract][Full Text] [Related]
39. Flavopiridol, a cyclin-dependent kinase inhibitor, prevents spindle inhibitor-induced endoreduplication in human cancer cells. Motwani M; Li X; Schwartz GK Clin Cancer Res; 2000 Mar; 6(3):924-32. PubMed ID: 10741717 [TBL] [Abstract][Full Text] [Related]
40. Involvement of p21(WAF1/Cip1), p27(Kip1), and p18(INK4c) in troglitazone-induced cell-cycle arrest in human hepatoma cell lines. Koga H; Sakisaka S; Harada M; Takagi T; Hanada S; Taniguchi E; Kawaguchi T; Sasatomi K; Kimura R; Hashimoto O; Ueno T; Yano H; Kojiro M; Sata M Hepatology; 2001 May; 33(5):1087-97. PubMed ID: 11343236 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]